This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1999 Jun 11;97(6):684-6; discussion 686-8.

doi: 10.1016/s0092-8674(02)09765-9.

Absence of BCL10 mutations in human malignant mesothelioma

S Apostolou¹, A De Rienzo, S S Murthy, S C Jhanwar, J R Testa

Affiliations

PMID: 10380921
DOI: 10.1016/s0092-8674(02)09765-9

Free article

Comment

Absence of BCL10 mutations in human malignant mesothelioma

S Apostolou et al. Cell. 1999.

Free article

. 1999 Jun 11;97(6):684-6; discussion 686-8.

doi: 10.1016/s0092-8674(02)09765-9.

Authors

S Apostolou¹, A De Rienzo, S S Murthy, S C Jhanwar, J R Testa

Affiliation

¹ Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.

PMID: 10380921
DOI: 10.1016/s0092-8674(02)09765-9

No abstract available

PubMed Disclaimer

Comment on

Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.
Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M, Price H, Karran L, Majekodunmi O, Wlodarska I, Pan L, Crook T, Hamoudi R, Isaacson PG, Dyer MJ. Willis TG, et al. Cell. 1999 Jan 8;96(1):35-45. doi: 10.1016/s0092-8674(00)80957-5. Cell. 1999. PMID: 9989495

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information
Molecular Biology Databases
- GlyGen glycoinformatics resource
Research Materials
- NCI CPTC Antibody Characterization Program